Craig-Hallum analyst George Sutton says that “on the surface,” eHealth’s preannounced Q4 results “look pretty good,” suggesting in-line revenue and a “healthy” EBITDA beat. However, the numbers included a meaningful “tail revenue” impact of $12M-$17M to achieve both the revenue and EBITDA results, the analyst tells investors in a research note. The firm says the tail revenues are a function of how the business gets accounted for under 606 accounting and is non-recurring. Hallum adds that actual Medicare Advantage approved members came in under 160,000, or a clear miss relative to expectations. That group is what we need to model the future from. The firm says the details of the preannouncement are “not so good” and keeps a Hold rating on the shares with a $7 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EHTH:
- eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2023
- eHealth sees Q4 revenue $241M-$249M, consensus $244.05M
- Craig-Hallum downgrades eHealth to Hold, lowers price target to $7
- eHealth downgraded to Hold from Buy at Craig-Hallum
Questions or Comments about the article? Write to editor@tipranks.com